The Role of Aldosterone in Vascular Permeability in Diabetes
Cells · 2026
DOI: 10.3390/cells15010089 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Michal Aleksiejczuk und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmacy and Radiopharmacy, Medical University of Bialystok, 15-222 Bialystok, Poland. Hauptthemen laut MEDLINE: Capillary Permeability, Diabetes Mellitus, Experimental, Aldosterone. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Bialystok.
Themen: Diabetes mellitus
Abstract (Originalsprache)
More than 30% of diabetic patients develop dermatopathies linked to inflammation and increased vascular permeability. Considering the role of the renin–angiotensin–aldosterone system (RAAS) in diabetic complications, this study examined whether aldosterone (ALDO) and the mineralocorticoid receptor (MR) contribute to diabetes-related skin microangiopathy. Vascular permeability was measured in normoglycemic rats and insulin-dependent (streptozotocin-induced) diabetic rats. The expression of MR, 11β-hydroxysteroid dehydrogenase type 2 (HSD11β2), vascular endothelial growth factor (VEGF), von Willebrand factor (vWF), and the tight junction protein ZO-1 was determined by PCR and immunohistochemistry. Diabetic rats received the MR antagonist eplerenone (EPL, 100 mg/kg) for 10 days. Additionally, the effects of ALDO and EPL on endothelial permeability were evaluated in human dermal microvascular endothelial cells (HMEC-1) using a Transwell system. Diabetic rats showed skin atrophy, collagen damage, elevated ALDO levels, reduced MR and HSD11β2 expression, and increased vascular permeability, along with upregulation of VEGF and vWF. EPL markedly reduced these abnormalities. In vitro, ALDO increased endothelial permeability under hyperglycemia, and EPL counteracted this effect. These findings indicate that activation of the ALDO/MR pathway promotes skin vascular permeability in diabetes through VEGF- and vWF-dependent mechanisms. MR blockade limits these changes, suggesting therapeutic potential in preventing diabetes-associated skin complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biopharmacy and Radiopharmacy, Medical University of Bialystok, 15-222 Bialystok, Poland.
- Radiopharmacy Centre, Medical University of Bialystok, 15-569 Bialystok, Poland.
- Department of Biochemistry, Medical University of Gdansk, 80-211 Gdansk, Poland.
- Department of Pharmaceutical and Biopharmaceutical Analysis, Medical University of Bialystok, 15-222 Bialystok, Poland.
- Department of Human Anatomy, Medical University of Bialystok, 15-222 Bialystok, Poland.
ORCID-Profile: Michal Aleksiejczuk, Natalia Bielicka, Magdalena Bruzgo-Grzybko, Izabela Suwda Kalita, Adam Jan Olichwier, Paulina Mierzejewska, Janusz Dzieciol, Ewa Chabielska, Anna Gromotowicz-Poplawska
Förderung
- Medical University of Bialystok
Zitieren
APA
Aleksiejczuk, M., Bielicka, N., Bruzgo-Grzybko, M., Kalita, I. S., Olichwier, A. J., Mierzejewska, P., Stelmaszewska, J., Dzieciol, J., Chabielska, E., & Gromotowicz-Poplawska, A. (2026). The Role of Aldosterone in Vascular Permeability in Diabetes. Cells. https://doi.org/10.3390/cells15010089
Vancouver
Aleksiejczuk M, Bielicka N, Bruzgo-Grzybko M, Kalita IS, Olichwier AJ, Mierzejewska P, et al. The Role of Aldosterone in Vascular Permeability in Diabetes. Cells. 2026. doi:10.3390/cells15010089
BibTeX
@article{Aleksiejczuk2026,
author = {Aleksiejczuk, Michal and Bielicka, Natalia and Bruzgo-Grzybko, Magdalena and Kalita, Izabela Suwda and Olichwier, Adam Jan and Mierzejewska, Paulina and Stelmaszewska, Joanna and Dzieciol, Janusz and Chabielska, Ewa and Gromotowicz-Poplawska, Anna},
title = {The Role of Aldosterone in Vascular Permeability in Diabetes},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15010089}
}
EUVIMED